BR0214960A - Pré-concentrado de microemulsão e preparação farmacêutica oral - Google Patents

Pré-concentrado de microemulsão e preparação farmacêutica oral

Info

Publication number
BR0214960A
BR0214960A BR0214960-5A BR0214960A BR0214960A BR 0214960 A BR0214960 A BR 0214960A BR 0214960 A BR0214960 A BR 0214960A BR 0214960 A BR0214960 A BR 0214960A
Authority
BR
Brazil
Prior art keywords
concentrate
pharmaceutical preparation
oral pharmaceutical
microemulsion
microemulsion pre
Prior art date
Application number
BR0214960-5A
Other languages
English (en)
Inventor
Jar Mook Choi
Eun Kyung Jeon
Jae Kyoung Ko
Young Hwan Park
Myoung Ki Baek
Su Geon Yang
Eun Ju Jeong
Original Assignee
Cj Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Corp filed Critical Cj Corp
Publication of BR0214960A publication Critical patent/BR0214960A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PRé-CONCENTRADO DE MICROEMULSãO E PREPARAçãO FARMACêUTICA ORAL". é provido um pré-concentrado de microemulsão, que compreende um componente ativo, um óleo, um agente tensioativo e um solvente hidrofílico selecionado do grupo que consiste em propileno glicol diacetato, propileno glicol monoacetato e sais dos materiais antecedentes.
BR0214960-5A 2001-12-27 2002-12-26 Pré-concentrado de microemulsão e preparação farmacêutica oral BR0214960A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2001-0085994A KR100441167B1 (ko) 2001-12-27 2001-12-27 마이크로에멀젼 예비 농축액 조성물
PCT/KR2002/002443 WO2003055466A1 (en) 2001-12-27 2002-12-26 Microemulsion preconcentrate

Publications (1)

Publication Number Publication Date
BR0214960A true BR0214960A (pt) 2004-12-28

Family

ID=36088114

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214960-5A BR0214960A (pt) 2001-12-27 2002-12-26 Pré-concentrado de microemulsão e preparação farmacêutica oral

Country Status (11)

Country Link
US (1) US20050118254A1 (pt)
EP (1) EP1458359A4 (pt)
JP (1) JP2005516959A (pt)
KR (1) KR100441167B1 (pt)
CN (1) CN1332648C (pt)
AU (1) AU2002359041A1 (pt)
BR (1) BR0214960A (pt)
IL (2) IL162421A0 (pt)
MX (1) MXPA04005913A (pt)
RU (1) RU2278657C2 (pt)
WO (1) WO2003055466A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100494096B1 (ko) * 2002-08-05 2005-06-13 한미약품 주식회사 감기약 성분을 함유하는 경구투여용 조성물
KR100577514B1 (ko) * 2003-10-21 2006-05-10 한미약품 주식회사 비페닐디메틸디카복실레이트, 및 카르두스 마리아누스추출물 또는 이로부터 정제된 실리빈을 함유하는 경구용마이크로에멀젼 조성물
PE20050596A1 (es) * 2003-12-19 2005-10-18 Novartis Ag Microemulsion que comprende un inhibidor renina
BRPI0506812B8 (pt) * 2004-02-13 2021-05-25 Bioavailability Inc composição base anidra auto-microemulsificável, microemulsão e método de preparação da composição base automicroemulsificável
WO2005089714A1 (ja) * 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited エマルション安定化製剤
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
WO2008058366A1 (en) * 2006-09-28 2008-05-22 Université de Montréal Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
SG179457A1 (en) 2006-12-01 2012-04-27 Anterios Inc Peptide nanoparticles and uses therefor
JP5850602B2 (ja) 2006-12-21 2016-02-03 サンテン・エス・エー・エス 眼科用水中油型乳剤を製造する方法
KR100866979B1 (ko) * 2007-03-23 2008-11-05 재단법인서울대학교산학협력재단 이트라코나졸을 함유한 마이크로이멀젼계 하이드로겔 및이의 제조방법
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
GB2451811A (en) * 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
KR101848095B1 (ko) * 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
ES2894340T3 (es) * 2009-03-09 2022-02-14 Basf As Composiciones que comprenden una mezcla de aceites de ácidos grasos y un tensioactivo, y métodos y usos de las mismas
WO2012016703A2 (en) * 2010-08-04 2012-02-09 Grünenthal GmbH Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine
KR20130097173A (ko) 2010-08-04 2013-09-02 그뤼넨탈 게엠베하 신경병증성 통증을 치료하기 위한 ６’­플루오로­（Ｎ­메틸­ 또는 Ｎ，Ｎ­디메틸­）­４­페닐­４’，９’­디하이드로­３’Ｈ­스피로[사이클로헥산­１，１’­피라노[３，４，ｂ]인돌]­４­아민을 포함하는 약제학적 투여형
EP2827839B1 (en) 2012-03-20 2019-02-27 Particle Dynamics International, LLC Gelling agent-based dosage form
US20160228397A1 (en) 2012-03-30 2016-08-11 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions
US9480651B2 (en) 2012-03-30 2016-11-01 Sancilio & Company, Inc. Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
JP6359517B2 (ja) 2012-03-30 2018-07-18 サンシリオ アンド カンパニー, インコーポレイテッドSancilio & Company, Inc. ω−３脂肪酸エステル組成物
US10898458B2 (en) 2012-03-30 2021-01-26 Micelle Biopharma, Inc. Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
CN104706591B (zh) * 2013-12-16 2018-09-04 天津迈迪瑞康生物医药科技有限公司 一种前列地尔药物组合物、其制备方法及用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
US5461064A (en) * 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
DK91494A (da) * 1994-08-05 1996-02-06 Andersen Irma Emballage
SE9503143D0 (sv) * 1995-09-12 1995-09-12 Astra Ab New preparation
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
CA2331640A1 (en) * 1998-05-07 1999-11-11 Elan Corporation Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
KR100342942B1 (ko) * 1999-07-05 2002-07-02 민경윤 카르두스 마리아누스 추출물 또는 이로부터 정제된 실리빈을함유하는 경구용 마이크로에멀젼 조성물
JP2001122779A (ja) * 1999-10-26 2001-05-08 Toyo Capsule Kk 経口投与用シクロスポリン含有ミクロエマルジョン濃縮液

Also Published As

Publication number Publication date
JP2005516959A (ja) 2005-06-09
AU2002359041A1 (en) 2003-07-15
US20050118254A1 (en) 2005-06-02
EP1458359A4 (en) 2007-05-30
KR20030055873A (ko) 2003-07-04
CN1332648C (zh) 2007-08-22
RU2278657C2 (ru) 2006-06-27
IL162421A (en) 2010-04-29
RU2004118489A (ru) 2005-04-20
CN1610538A (zh) 2005-04-27
IL162421A0 (en) 2005-11-20
KR100441167B1 (ko) 2004-07-21
WO2003055466A1 (en) 2003-07-10
MXPA04005913A (es) 2004-09-13
EP1458359A1 (en) 2004-09-22

Similar Documents

Publication Publication Date Title
BR0214960A (pt) Pré-concentrado de microemulsão e preparação farmacêutica oral
EA200400765A1 (ru) Фармацевтические составы, содержащие соединения активного витамина d
BR0111016A (pt) Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BR0209919A (pt) Composições pesticidas lìquidas estáveis
DE59909759D1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
BR9814924B1 (pt) microgránulos de omeprazol, processo de preparação dos mesmos, e, preparações farmacêuticas.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
BR9911505A (pt) Artigos de lenços tratados.
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
FR2720943B1 (fr) Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
FI935396L (fi) Uudet nanopartikkelien muodossa olevat, veren röntgenvarjoainekoostumukset, joissa on suuren molekyylipainon pinta-aktiivista ainetta
ATE415952T1 (de) Vor missbrauch geschützte opioid-haltige transdermale systeme
NO20034149L (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
DK0627163T3 (da) Fungicide kombinationer af aktive stoffer
ATE395071T1 (de) Pharmazeutische zubereitungen zur angiogenese- therapie
CA2326222A1 (en) Medicinal compositions
BR0108738A (pt) Formulações anestésicas
BR0215187A (pt) Composições farmacêuticas que compreendem uma ciclosporina, um tensoativo hidrofìlico e um tensoativo lipofìlico
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
DE60142305D1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
ATE339371T1 (de) Verpackungsmittel zur aufnahme einer blisterpackung

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: CJ CORPORATION (KR)

Free format text: A FIM DE ATENDER A TRANSFERENCIA SOLICITADA ATRAVES DA PETICAO NO 020090000043/RJ DE 02/01/2009, AMESMA DEVE ESTAR DEVIDAMENTE ASSINADA PELO TITULAR OU POR SEU PROCURADOR.

B25A Requested transfer of rights approved

Owner name: CJ CHEILJEDANG CORPORATION (KR)

Free format text: TRANSFERIDO DE: CJ CORPORATION

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI.A61K 9/107, A61P 37/06

Ipc: A61K 9/107 (2011.01), A61P 37/06 (2011.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.